Login

Stefan Poz on Moonfare's Mission and the Impact of ELTIF 2.0 00:10:00

Share On Facebook Share On Twitter

Dr. Steffen Pauls, CEO and Founder at Moonfare. Former Managing Director at KKR

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Robbie Cooke, CEO of Tyro, Shares Insights in Special Interview | Robbie Cooke, CEO, Tyro Payments Ltd.
00:10:00
Discovery Days: Critical Metals Presentation by Michael Gray | Agentis Capital
00:10:00
CEO Robert Cameron Advocates Prospect Generator Model for Commander Resources Ltd. | Robert Cameron, President & CEO of Commander Resources Ltd.
00:10:00
Legal Insights: Panel with Evan Chesler and NYU Law Professors | Evan R. Chesler - RETIRED PARTNER of Cravath, Swaine & Moore LLP
00:10:00
Lincoln Investment: Empowering Advisors with Growth and Innovation
00:10:00
Labor Market Imbalances: A Challenge for the Federal Reserve
00:10:00
Jonathan Thomas on Market Volatility, Investment Strategies, and Philanthropy | Jonathan Thomas, CEO , American Century Investments.
00:00:00
Fulvio Citaredo, CEO di Pierrel Spa
00:10:00
Lithium Supply Needs to Increase Fivefold by 2030
00:00:00
Mario Hevesi, M.D., Ph.D. Orthopedic Surgeon, Mayo Clinic
00:10:00
Volume driven by electric vehicle growth, surging lithium demand, and the evolving landscape for battery supply chains|Kent Masters,CEO,Albemarle
00:10:00
Global Leaders in RNAi Therapeutics: Sirnaomics’ Commitment to Patient-Centered Care | Patrick Y. Lu , CEO, Sirnaomics Ltd.

© 2017 - Neuhu+